Antigen Discovery receives $2.5M grant for malaria vax

California's Antigen Discovery nailed down a $2.5 million federal grant to continue work on a malaria vaccine, according to The Orange County Register. This isn't the first time the company has seen federal dollars for its work; the company has raked in $14 million in federal grants under the Small Business Innovation Research and Small Business Technology Transfer Research programs. The newest three-year grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases will go toward a joint research effort between Antigen and Maryland-based vaccine oufit Sanaria for the malaria vaccine. Story

Like what you're reading
Click here to get more news delivered to your inbox every week>>

Suggested Articles

Merck has a big target in mind for its pneumococcal vaccine V114: Prevnar 13, the world's best-selling shot—and its phase 3 program shows it.

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

Behind the under-pressure blockbuster Prevnar 13 are several pipeline vaccines Pfizer hopes will propel future growth.